Paving the way for the prevention of valvular diseases

• by Louis-Marie Desroche, Victor Aboyans

• November 27, 2025

Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation

• by Yuhang Wei, Chenxi Cao, Yunzhe Wang, Pengli Yang, Wenjing Zhang, Jiahong Shangguan, Xijia Wang, Jiaqi Gao, Wenzhe Zong, Gangqiong Liu

• May 15, 2026

Association between blood pressure levels and risk of stroke in patients with atrial fibrillation: results from a prospective registry in Xinjiang, China

• by Bizhong Che, Meidina Yeerken, Kangting Luo, Wen Peng, Meng Wei, Xu Yang, Yanmei Lu, Xianhui Zhou, Hua Wang, Fubing Ma, Yunguo Chen, Youfa Wang, Baopeng Tang

• May 29, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min